FS KKR Cap Corp (FSK)

FINANCE: GENERAL FINANCE
SIC:

201 ROUSE BOULEVARD PHILADELPHIA, PA 19112

FS Investment Corporation is an externally managed, non-diversified, closed-end management investment company that has elected to be treated for federal income tax purposes as a regulated investment company. The company invests in the debt securities of established private companies with strong cash flows.

Data as of 2020-08-01
Market Cap1.968 Billion Shares Outstanding123.758 Million Avg 30-day Volume864.478 Thousand
P/E Ratio Dividend Yield15.094 EPS-4.48
Price/Sales-3.912 Price cash flow ratio12.4 Price free cash flow ratio-2.6
Book Value24.47 Price to Tangible Book0.65 Alpha-0.02
Short Interest Ratio3.04 % Short Interest to Float2.9 R-squared0.758163
BETA1.95887 52-week High/Low25.52 / 7.6 Stddev0.1307
View SEC Filings from FSK instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 10 5 (0.33%)
13F Filers holding this stock: 313 53 (3.47%)
Aggregate 13F shares on 03/31/2020: 158.414 Million 61.841 Million
Aggregate 13F shares on 12/31/2019: 150.345 Million 52.369 Million
Percent change: 5.37% 18.09%
Funds creating new positions: 39 10
Funds Adding to an existing position: 101 17
Funds closing out their position: 63 26
Funds reducing their position: 108 17
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

 
FS KKR Cap Corp Chart by YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Check out our reporting and analysis

Funds Holding FSK (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding FSK BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MARSHALL BRAD CEO

  • Officer
  • TRUSTEE
 62,500 2020-07-14 0

SCARPATI GERARD CHIEF COMPLIANCE OFFICER

  • Officer
 0 2020-06-26 0

FORMAN MICHAEL C. PRESIDENT & CEO

  • Officer
  • Director
  • 10% Owner
 3,251,960 2020-06-17 1

ADELMAN DAVID J.

  • Director
  • 10% Owner
 3,243,248 2020-06-17 0

KROPP JAMES H

  • Director
 14,761 2020-06-05 1

GERSON BRIAN CO-PRESIDENT

  • Officer
 0 2020-06-01 6

FORD BRIAN R.

  • Director
 45,303 2020-06-01 2

BUILIONE TODD C.

  • Director
 12,500 2020-05-29 2

PIETRZAK DANIEL CO-PRESIDENT AND CIO

  • Officer
 50,000 2020-05-29 6

GOLDSTEIN RICHARD I

  • Director
 57,100 2020-05-14 5

ARNOLD FREDERICK

  • Director
 35,235 2020-05-13 0

SYPHERD STEPHEN SEE REMARKS

  • Officer
 12,554 2020-04-29 0

VOLK JAMES FRANCIS CHIEF COMPLIANCE OFFICER

  • Officer
 0 2020-04-29 0

LILLY STEVEN C

  • Director
 4,750 2020-03-19 1

IMASOGIE OSAGIE O

  • Director
 34,658 2020-03-04 2

SANDLER ELIZABETH

  • Director
 3,560 2020-03-04 2

HARROW JEFFREY

  • Director
 38,214 2019-12-18 0

GOEBEL WILLIAM BALKE CHIEF ACCOUNTING OFFICER

  • Officer
 8,873 2019-12-18 0

HOPKINS JEREL A

  • Director
 11,868 2019-12-18 0

ADAMS BARBARA

  • Director
 10,927 2019-12-18 1

HAGAN MICHAEL J

  • Director
 112,100 2019-09-09 1

RAMOS PEDRO A

  • Director
 0 2019-08-21 0

UJOBAI JOSEPH P

  • Director
 0 2018-12-03 0

KLEHR ZACHARY EXECUTIVE VICE PRESIDENT

  • Officer
 88,860 2018-06-07 0

CHANDLER GREGORY P

  • Director
 19,816 2018-04-30 0

RIDGE THOMAS J

  • Director
 35,884 2018-04-01 0

HELLER MICHAEL

  • Director
 55,401 2018-03-20 0

FRANK BARRY

  • Director
 94,287 2018-03-06 0

GRAVINA THOMAS

  • Director
 100,000 2018-01-09 0

KELLY MICHAEL JOHN

  • INVESTMENT COMMITTEE MEMBER
 35,000 2017-12-28 0

COLEMAN SEAN K

  • INVESTMENT COMMITTEE MEMBER
 0 2017-12-11 0

STAHLECKER GERALD EVP

  • Officer
  • INVESTMENT COMM MEMBER
 0 2017-06-20 0

HUGHES PHILIP E JR

  • Director
 0 2017-06-20 0

JACOBSON CHARLES M CFO AND TREASURER

  • Officer
  • Director
 0 2015-08-21 0

MENDELSON PAUL

  • Director
 No longer subject to file 2015-04-01 0

FAIA SALVATORE ROCCO CHIEF COMPLIANCE OFFICER

  • Officer
 0 2014-08-25 0

CONLEY RYAN D. VP, TREASURER AND SECRETARY

  • Officer
 11,112 2011-07-18 0

LOTMAN HERBERT

  • Director
 0 2010-09-01 0

NEW IRELAND FUND INC CHIEF COMPLIANCE OFFICER

  • Officer
 0 2008-09-18 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments